0001426332-15-000001.txt : 20150224
0001426332-15-000001.hdr.sgml : 20150224
20150223212417
ACCESSION NUMBER: 0001426332-15-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20150224
DATE AS OF CHANGE: 20150223
EFFECTIVENESS DATE: 20150224
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: NGM BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001426332
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-234589
FILM NUMBER: 15641649
BUSINESS ADDRESS:
STREET 1: 630 GATEWAY BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-243-5555
MAIL ADDRESS:
STREET 1: 630 GATEWAY BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
D
1
primary_doc.xml
X0707
D
LIVE
0001426332
NGM BIOPHARMACEUTICALS INC
630 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO
CA
CALIFORNIA
94080
650-243-5555
DELAWARE
None
None
Corporation
true
Jin-Long
Chen
c/o NGM Biopharmaceuticals, Inc.
630 Gateway Boulevard
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
William
J.
Rieflin
c/o NGM Biopharmaceuticals, Inc.
630 Gateway Boulevard
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
David
V.
Goeddel
c/o NGM Biopharmaceuticals, Inc.
630 Gateway Boulevard
South San Francisco
CA
CALIFORNIA
94080
Director
Mark
Leschly
c/o Rho Ventures
525 University Ave., Suite 1350
Palo Alto
CA
CALIFORNIA
94301
Director
David
Schnell
c/o Prospect Ventures, L.P.
435 Tasso St., Suite 200
Palo Alto
CA
CALIFORNIA
94301
Director
Peter
Svennilson
c/o NGM Biopharmaceuticals, Inc.
630 Gateway Boulevard
South San Francisco
CA
CALIFORNIA
94080
Director
McHenry
T.
Tichenor, Jr.
c/o Tichenor Ventures, LLC
100 Crescent Court, Suite 700
Dallas
TX
TEXAS
75201
Director
Biotechnology
Decline to Disclose
- 06b
false
2014-10-09
false
true
true
Sale and issuance of Series D preferred stock and the underlying shares of common stock issuable upon conversion thereof.
false
0
60000000
20710000
39290000
false
20
0
0
0
false
NGM BIOPHARMACEUTICALS INC
/s/Barbara Kosacz
Barbara Kosacz
Secretary
2015-02-23